Compare · ACN vs OPRX
ACN vs OPRX
Side-by-side comparison of Accenture plc (ACN) and OptimizeRx Corporation (OPRX): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ACN and OPRX operate in Real Estate (Real Estate), so they compete in similar markets.
- ACN is the larger of the two at $116.02B, about 1224.3x OPRX ($94.8M).
- Over the past year, ACN is down 44.9% and OPRX is down 65.8% - ACN leads by 20.9 points.
- ACN has been more active in the news (35 items in the past 4 weeks vs 6 for OPRX).
- ACN has more recent analyst coverage (25 ratings vs 11 for OPRX).
- Company
- Accenture plc
- OptimizeRx Corporation
- Price
- $174.44-2.16%
- $5.05-1.27%
- Market cap
- $116.02B
- $94.8M
- 1M return
- -3.27%
- -23.83%
- 1Y return
- -44.90%
- -65.81%
- Industry
- Real Estate
- Real Estate
- Exchange
- NYSE
- NASDAQ
- IPO
- 2001
- News (4w)
- 35
- 6
- Recent ratings
- 25
- 11
Accenture plc
Accenture plc, a professional services company, provides strategy and consulting, interactive, and technology and operations services worldwide. The company also provides outsourcing services. It serves communications, media, high tech, software, and platform companies; banking, capital market, and insurance industries; and consumer goods, retail, travel services, industrial, and life science industries, as well as clients in health, public service, chemicals and natural resources, energy, and utility sectors. Accenture plc has alliance relationships with Adobe, Alibaba, Amazon Web Services, Blue Yonder, Cisco, Dell, Google, HPE, IBM RedHat, Microsoft, Oracle, Pegasystems, Salesforce, SAP, ServiceNow, VMWare, Workday, Massachusetts Institute of Technology, Institut Polytechnique de Paris, CNH Industrial, and Reactive Technologies. It has an agreement with Duke Energy Corporation for the development of a technology platform designed to measure actual baseline methane emissions from natural gas distribution systems. The company was incorporated in 2009 and is based in Dublin, Ireland.
OptimizeRx Corporation
OptimizeRx Corporation operates as a digital health company that provides communications solutions for life science companies, physicians, and patients. Its products and applications include financial messaging, a virtual patient support center that allows doctors and staff to access sample vouchers, co-pay coupons, and other patient support through their EMR and/or e-prescribe systems; and brand awareness and therapeutic support messaging services, such as brand awareness messages, reminder ads, therapeutic support messages, and unbranded messages. The company also offers brand support services, which focuses on educating and working with pharmaceutical manufacturers on identifying, formulating, and implementing new eRx media strategies, including drug file integration, sales force training, and strategy development services for promoting their products. In addition, it operates cloud based Mobile Health Messenger platform that provides interactive health messaging for enhanced medication adherence and care coordination; and HIPAA-compliant automated mobile messaging platform that allows pharmaceutical manufactures and related entities to directly engage with patients to enhance regimen compliance. Further, the company offers patient programs with treatment and affordability information, lifestyle and condition trackers, Internet device connectivity, forms, and surveys. OptimizeRx Corporation is headquartered in Rochester, Michigan.
Latest ACN
- Chief Accounting Officer Burgum Melissa A was granted 112 units of Class A ordinary shares, increasing direct ownership by 1% to 8,579 units (SEC Form 4)
- General Counsel/Corp Secretary Unruch Joel was granted 153 units of Class A ordinary shares, increasing direct ownership by 0.55% to 28,031 units (SEC Form 4)
- Chief Leadership & HR Officer Clifford Katherine Lee was granted 98 units of Class A ordinary shares, increasing direct ownership by 2% to 6,531 units (SEC Form 4)
- CEO-The Americas Walsh John F was granted 153 units of Class A ordinary shares, increasing direct ownership by 0.60% to 25,722 units (SEC Form 4)
- Chair and CEO Sweet Julie Spellman was granted 216 units of Class A ordinary shares, increasing direct ownership by 1% to 16,235 units (SEC Form 4)
- Chief Financial Officer Park Angie Y was granted 153 units of Class A ordinary shares, increasing direct ownership by 1% to 13,118 units (SEC Form 4)
- Chief Operating Officer Hogan Catherine Kiernan was granted 119 units of Class A ordinary shares, increasing direct ownership by 0.90% to 13,321 units (SEC Form 4)
- Chief Strategy & Services Ofcr Sharma Manish was granted 102 units of Class A ordinary shares, increasing direct ownership by 2% to 5,545 units (SEC Form 4)
- Accenture to Acquire Leading Creator and Social Agency Whalar, from Whalar Group
- Accenture and the Carnegie Mellon University Software Engineering Institute Launch AI Adoption Maturity Model to Help Organizations Scale AI with Predictable Outcomes
Latest OPRX
- OptimizeRx Corporation filed SEC Form 8-K: Leadership Update
- SEC Form DEFA14A filed by OptimizeRx Corporation
- OptimizeRx to Participate in Upcoming Investor Conferences
- DeepIntent Becomes First Healthcare DSP to Integrate OptimizeRx's Authenticated EHR Network
- Chief Commercial Officer Greco Theresa covered exercise/tax liability with 1,793 shares, decreasing direct ownership by 2% to 71,075 units (SEC Form 4) (withholding obligation)
- Chief Executive Officer Silvestro Stephen L covered exercise/tax liability with 5,219 shares, decreasing direct ownership by 3% to 185,288 units (SEC Form 4) to satisfy withholding tax
- SEC Form 10-Q filed by OptimizeRx Corporation
- OptimizeRx Corporation filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Results of Operations and Financial Condition, Creation of a Direct Financial Obligation, Financial Statements and Exhibits
- OptimizeRx Reports First Quarter 2026 Financial Results and Updates Fiscal Year 2026 Guidance
- OptimizeRx Launches Programmatic Access to Authenticated EHR Advertising at Scale